when were glp 1 agonists approved for weight loss Indications GLP-1/GIP RA Summary Sheet and Beyond! Is GLP-1 the Same as

Some even suggest that GLP-1 agonists might have the potential to supplant MASH therapy in its entirety

Clinical Significance: The 2025 updates reaffirm that while HbA1c remains central, a one-number-fits-all strategy is outdated

Beyond these frontrunners, the pipeline is expanding: Novo Nordisk filed for FDA approval of CagriSema in 2025, the first once-weekly combination of GLP1 and amylin analogue

Evaluating what the research shows about GLP-1 medications and depression and suicidal ideation.

Study Selection We selected pharmacokinetic studies of any injectable GLP1RA given with an oral medication, and product prescribing sheets reporting data without access to the original study